| Literature DB >> 35975912 |
Olli-Pekka Nuuttila1, Ari Nummela2, Elisa Korhonen1, Keijo Häkkinen1, Heikki Kyröläinen1.
Abstract
PURPOSE: Long-term development of endurance performance requires a proper balance between strain and recovery. Because responses and adaptations to training are highly individual, this study examined whether individually adjusted endurance training based on recovery and training status would lead to greater adaptations compared with a predefined program.Entities:
Mesh:
Year: 2022 PMID: 35975912 PMCID: PMC9473708 DOI: 10.1249/MSS.0000000000002968
Source DB: PubMed Journal: Med Sci Sports Exerc ISSN: 0195-9131
Mean ± SD baseline characteristics of the participants.
| PD | IND | |||||
|---|---|---|---|---|---|---|
| Males ( | Females ( | All ( | Males ( | Females ( | All ( | |
| Age (yr) | 33 ± 6 | 35 ± 8 | 34 ± 7 | 37 ± 5 | 38 ± 9 | 37 ± 7 |
| Height (cm) | 181 ± 3 | 168 ± 5 | 174 ± 8 | 180 ± 5 | 167 ± 8 | 174 ± 9 |
| Body mass (kg) | 82 ± 11 | 64 ± 8 | 73 ± 13 | 77 ± 12 | 59 ± 4 | 68 ± 13 |
| BMI (kg·m−2) | 25.0 ± 3.5 | 22.7 ± 3.3 | 23.9 ± 3.5 | 23.7 ± 3.7 | 21.3 ± 1.2 | 22.5 ± 3.0 |
| Fat (%) | 14.9 ± 5.1 | 21.0 ± 7.1 | 17.9 ± 6.7 | 12.0 ± 5.6 | 19.8 ± 4.8 | 15.9 ± 6.5 |
| V̇O2max (mL·kg1·min−1) | 47.9 ± 4.2 | 43.4 ± 2.5 | 45.7 ± 4.0 | 50.6 ± 6.2 | 42.3 ± 4.3 | 46.5 ± 6.7 |
Baseline characteristics were measured before the preparatory period (T0).
BMI, body mass index.
The training program of the PD group during the preparatory (PREP1–3), volume (VOL1–6), and interval (INT1–6) training periods.
| Week | LIT (Basic), 30–90 min | LIT (Long), >90 min | MOD, 30 min | HIT, 6 × 3 min | Tests V̇O2max, 10 km | Volume |
|---|---|---|---|---|---|---|
|
| 1–3× | x | ||||
| PREP1 | 2–4× | 1× | 1× | BL | ||
| PREP2 | 2–4× | 1× | 1× | BL | ||
| PREP3 | 1–3× | 1× | 1× | 0.75 × BL | ||
|
| 1–3× | × | ||||
| VOL1 | 2–4× | 1× | 1× | 1.1 × BL | ||
| VOL2 | 2–4× | 1× | 1× | 1.2 × BL | ||
| VOL3 | 1–3× | 1× | 1× | 0.75 × previous wk | ||
| VOL4 | 2–4× | 1× | 1× | 1.3 × BL | ||
| VOL5 | 2–4× | 1× | 1× | 1.4 × BL | ||
| VOL6 | 1–3× | 1× | 1× | 0.75 × previous wk | ||
|
| 1–3× | × | ||||
| INT1 | 1–3× | 3× | BL (basic sessions) | |||
| INT2 | 1–3× | 3× | BL (basic sessions) | |||
| INT3 | 2–4× | 1× | 0.75 × previous wk | |||
| INT4 | 1–3× | 3× | BL (basic sessions) | |||
| INT5 | 1–3× | 3× | BL (basic sessions) | |||
| INT6 | 2–4× | 1× | 0.75 × previous wk | |||
|
| 1–3× | × |
All MOD and HIT sessions also included low-intensity warm-up and cool-down.
BL, baseline; LIT, low-intensity training (HRzone1); MOD, moderate-intensity training (HRzone2); HIT, high-intensity interval training (maximal sustainable effort); V̇O2max, incremental treadmill test.
FIGURE 1Determination logic of the training load in the IND group. Training load was adjusted twice a week on evaluation days (Monday and Thursday). If the training load was maintained, no modifications were made compared with the current level. The training load was increased via adding volume (VOL) by 5% (e.g., 1.10 × baseline level to 1.15 × baseline level) or via increasing the number of HIT sessions (INT). The training load was decreased via reducing volume by 25% compared with the current level (VOL), or via reducing volume by 25% from the current level and excluding HIT sessions (INT). After the recovery block, the training continued from the level preceding the recovery block (two-thirds of the markers within normal range) or the next level (VOL). During INT, the progression always started from one HIT. After reaching a maximum number of HIT sessions within a block (two or three sessions), no additional sessions were performed. After the last evaluation day of INT, a maximum of one HIT session was performed to ensure sufficient recovery before final tests.
FIGURE 2Training volume, running distance, and training intensity distribution (time in HRzone1, HRzone2, and HRzone3) at baseline (PREP) and across the volume (VOL1–VOL6) and interval (INT1–INT6) training periods in the PD (A) and IND (B) training groups.
Mean ± SD performance and laboratory test results before the VOL (T1) between the VOL and INT (T2), and after the INT (T3) periods.
| PD ( | IND ( | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| vLT1 (km·h−1) | 10.7 ± 0.9 | 10.8 ± 1.1 (0.10; −0.43 to 0.63) | 11.1 ± 1.2 (0.33; −0.21 to 0.87) | 10.6 ± 1.1 | 10.8 ± 1.0 (0.23; −0.27 to 0.72) | 10.8 ± 1.3 (0.14; −0.36 to 0.63) |
| vLT2 (km·h−1) | 13.3 ± 1.4 | 13.5 ± 1.5 (0.15,. −38 to 0.67) | 13.6 ± 1.6* (0.18; −0.35 to 0.70) | 13.1 ± 1.6 | 13.3 ± 1.4 (0.16; −0.33 to 0.65) | 13.5 ± 1.6** (0.23; −0.27 to 0.72) |
| vMax (km·h−1) | 16.1 ± 1.8 | 16.3 ± 2.0 (0.11; −0.42 to 0.63) | 16.6 ± 2.1***,† (0.26; −0.28 to 0.79) | 16.0 ± 2.0 | 16.2 ± 2.0 (0.10; −0.39 to 0.59) | 16.6 ± 1.9***,†† (0.32; −0.19 to 0.82) |
| V̇O2max (mL·kg−1·min−1) | 46.7 ± 3.9 | 47.8 ± 5.2 (0.26; −0.28 to 0.78) | 50.7 ± 6.1***,††† (0.80; −0.18;1.39) | 47.3 ± 7.2 | 47.0 ± 7.2 (−0.03; −0.49 to 0.44) | 50.3 ± 7.6**,††† (0.40; −0.12 to 0.90) |
| CMJ (cm) | 28.0 ± 5.2 | 28.8 ± 4.7 (0.15; −0.38 to 0.67) | 28.6 ± 4.4 (0.11; −0.41 to 0.64) | 30.3 ± 6.3 | 30.6 ± 6.8 (0.05; −0.44 to 0.54) | 30.0 ± 6.2 (−0.05; −0.54 to 0.44) |
| fTesto (pmol·L−1) | 27.0 ± 26.6 | 26.9 ± 25.5 (0.00; −0.69 to 0.69) | 27.3 ± 23.3 (0.00; −0.69 to 0.69) | 18.6 ± 17.5 | 18.2 ± 16.8 (−0.01; −0.75 to 0.73) | 18.6 ± 16.4 (0.00; −0.74 to 0.74) |
| Cortisol (nmol·L−1) | 382 ± 102 | 439 ± 107 (0.50; −0.07;1.04) | 411 ± 96 (0.24; −0.30 to 0.76) | 464 ± 145 | 468 ± 145 (0.02; −0.47 to 0.51) | 456 ± 125 (−0.06; −0.55 to 0.43) |
| CK (umol·L−1) | 130 ± 63 | 148 ± 90 (0.06; −0.63 to 0.75) | 115 ± 54 (−0.07; −0.76 to 0.62) | 118 ± 55 | 130 ± 65 (0.05; −0.69 to 0.79) | 129 ± 79 (0.05; −0.69 to 0.79) |
Values in the parentheses are ES (Cohen’s d) and the 95% confidence intervals for the within-group changes from T1.
*P < 0.05 within groups compared with T1.
**P < 0.01 within groups compared with T1.
***P < 0.001 within groups compared with T1.
†P < 0.05 within groups compared with T2.
††P < 0.01 within groups compared with T2.
†††P < 0.001 within groups compared with T2.
CK, serum creatine kinase. fTesto, serum free testosterone; vLT1, the speed at the first lactate threshold; vLT2, the speed at the second lactate threshold; vMax, maximal speed of the incremental treadmill test.
FIGURE 3Running time in the 10-km test before the VOL (T1), between the VOL and INT (T2), and after the INT (T3) periods in the PD and IND training groups. **P < 0.01, ***P < 0.001 within groups compared with T1 +++P < 0.001 within groups compared with T2.
FIGURE 4Magnitude of individual responses and mean changes (black rectangle) in maximal treadmill speed (A) and 10-km running time (B). Magnitudes were set based on the CV of the parameter between T0 and T1. High + and Moderate + indicate improved performance; Trivial ±, unchanged performance; and Moderate −, impaired performance.
FIGURE 5Mean ± SD baseline values (PREP) and weekly changes (VOL1–6, INT1–6) in nocturnal HR (A), nocturnal LnRMSSD (B), staleness score (C), and HR–RS index (D). Gray area represents the SWC of the parameter based on individual average values during PREP. In A and B = 0.5 × CV, in C and D = 0.5 × SD. *P < 0.05, **P < 0.01, ***P < 0.001 within groups compared with PREP. #P < 0.05 between groups at respective time point.